Standard Biotools (LAB) Return on Capital Employed (2011 - 2026)
Standard Biotools (LAB) posted quarterly Return on Capital Employed of 17.07% for Q1 2026, up 332.0% year-over-year from 3.95% in Q1 2025, and up 31.06% quarter-over-quarter from 24.75% in Q4 2025.
Standard Biotools (LAB) Return on Capital Employed (2011 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Return on Capital Employed for 16 consecutive years, with 17.07% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed rose 332.0% year-over-year to 17.07%; the TTM figure through Mar 2026 stood at 17.07% (up 332.0% YoY), while the FY2025 annual figure was 22.89%, up 884.0% from the prior year.
- Return on Capital Employed grew to 17.07% in Q1 2026 per LAB's latest filing, from 24.75% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 17.07% in Q1 2026 and bottomed at 61.66% in Q1 2022.
- Historically, Return on Capital Employed has averaged 30.04% across 5 years, with a median of 25.81% in 2023.
- Annual changes were most pronounced in 2022 — Return on Capital Employed sank 4047 bps — and 2023, when it jumped 3044 bps.
- Standard Biotools' Return on Capital Employed stood at 32.35% in 2022, then declined by 7 bps to 34.53% in 2023, then gained by 29 bps to 24.65% in 2024, then retreated by 0 bps to 24.75% in 2025, then soared by 31 bps to 17.07% in 2026.
- Business Quant data shows LAB's Return on Capital Employed at 17.07% in Q1 2026, 24.75% in Q4 2025, and 25.36% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn | 12.08% |
| 10 | Standard Biotools | 252.90 Mn | -223.82 Mn | 10.54 Mn | -16.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.56% |
| Mar 31, 2026 | -17.07% |
| Dec 31, 2025 | -24.75% |
| Sep 30, 2025 | -25.36% |
| Jun 30, 2025 | -22.42% |
| Mar 31, 2025 | -20.38% |
| Dec 31, 2024 | -24.65% |
| Sep 30, 2024 | -24.11% |
| Jun 30, 2024 | -21.47% |
| Mar 31, 2024 | -28.03% |
| Dec 31, 2023 | -34.53% |
| Sep 30, 2023 | -25.81% |
| Jun 30, 2023 | -26.56% |
| Mar 31, 2023 | -31.23% |
| Dec 31, 2022 | -32.35% |
| Sep 30, 2022 | -39.62% |
| Jun 30, 2022 | -50.63% |
| Mar 31, 2022 | -61.66% |
| Sep 30, 2021 | -54.10% |
| Jun 30, 2021 | -32.03% |